Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan : A Randomized Phase 2 Trial by the Cancer and Leukemia Group B (CALGB 19803)
David L. Grinblatt, Daohai Yu, Vera Hars, James W. Vardiman, Bayard L. Powell, Sreenivasa Nattam, Lewis R. Silverman, Carlos de Castro III, Richard M. Stone, Clara D. Bloomfield, Richard A. Larson, foVolume:
115
Year:
2009
Language:
english
Pages:
10
DOI:
10.1002/cncr.23995
File:
PDF, 156 KB
english, 2009